Recent Negative Cytology Prior to Histologically Confirmed Carcinoma in Situ of the Cervix
- 1 May 1994
- journal article
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 34 (2) , 178-181
- https://doi.org/10.1111/j.1479-828x.1994.tb02685.x
Abstract
Women with histologically confirmed carcinoma in situ of the cervix were studied within the records of the Victorian Cervical Cytology Registry. The prevalence of histologically confirmed carcinoma in situ during 1992 was 2.67 per 1,000 women screened. Thirty per cent (401 of 1,327) of the women with carcinoma in situ had negative cervical cytology reported during the 2 years prior to the diagnosis of carcinoma in situ and at least 49% (648 of 1,327) had negative cytology during the preceding 5 years. Adenocarcinoma in situ comprised 3.4% of all cases; these women were significantly older and more likely to have had a recent negative smear report than women with squamous carcinoma in situ. Fifty-five per cent of the women with squamous carcinoma in situ had HPV reported on the biopsy compared with only 27% of the women with adenocarcinoma in situ. Ten per cent of the women with carcinoma in situ had a past history of cytological or histological abnormality; this proportion did not vary by type of carcinoma in situ. This relatively high proportion of negative cytology in close proximity to a diagnosis of carcinoma in situ is to be expected if there is active treatment of lesser lesions and frequent screening of members of the community.Keywords
This publication has 7 references indexed in Scilit:
- Rationale for stopping cervical screening in women over 50.BMJ, 1993
- Improving cervical screening by involving general practitionersThe Lancet, 1991
- Adenocarcinoma of the uterine cervix prognosis and patterns of failure in 367 casesCancer, 1990
- Screening for cancer of the cervix in elderly womenThe Lancet, 1990
- Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.BMJ, 1986
- Adenocarcinoma of the cervix: Histopathologic and clinical featuresAmerican Journal of Obstetrics and Gynecology, 1977
- ADENOCARCINOMA OF THE UTERINE CERVIX A CLINICAL AND PATHOLOGICAL APPRAISALBJOG: An International Journal of Obstetrics and Gynaecology, 1976